Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) was downgraded by investment analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research note issued to investors on Monday, Marketbeat Ratings reports. AMLX has been the topic of a number of other reports. The Goldman Sachs Group reissued a “neutral” rating […]
The Goldman Sachs Group restated their neutral rating on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Free Report) in a report released on Friday morning, Marketbeat Ratings reports. Several other brokerages have also recently issued reports on AMLX. Robert W. Baird assumed coverage on shares of Amylyx Pharmaceuticals in a report on Wednesday, January 3rd. They […]
Evercore ISI Reiterates In-Line Rating for Amylyx Pharmaceuticals (NASDAQ:AMLX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Insider Sells $28,844 20 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) insider Gina Mazzariello sold 1,540 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $18.73, for a total value of $28,844.20. Following the completion of the sale, the insider now directly owns 81,372 shares of […]